Research Article
Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait?
Table 2
UL54 mutations in clinical CMV isolates resistant to GCV [
9].
| | Region | UL54 mutation | Amino acid change |
| | IV | N408D F412C D413E | Asparagine to aspartic acid Phenylalanine to cycteine Aspartic acid to glutamic acid |
| | δ-region C | L501F | Leucine to phenylalanine | | L501I | Leucine to isoleucine | | T503I | Threonine to isoleucine | | K503R | Lysine to arginine | | K513E | Lysine to glutamic acid | | P522A | Proline to alanine | | T700A | Threonine to alanine |
| | II | T700A | Threonine to alanine | | M715V | Valine to methionine | | I722V | Isoleucine to valine |
| | VI | V781I | Valine to isoleucine |
| | III | L802M | Leucine to methionine | | A809V | Alanine to valine | | G841A | Glycine to alanine |
| | Other | S676G | Serine to glycine | | G678S | Glycine to serine | | Y751H | Tyrosine to histidine |
|
|